Skip to main content
Clinical Trials/NCT06586346
NCT06586346
Not Yet Recruiting
N/A

Frequency, Predictors and Outcome of Sepsis Induced Coagulopathy in Critical Care Unit

Assiut University0 sites100 target enrollmentSeptember 10, 2024
ConditionsCoagulopathy

Overview

Phase
N/A
Intervention
Not specified
Conditions
Coagulopathy
Sponsor
Assiut University
Enrollment
100
Primary Endpoint
Assess frequency and severity of sepsis induced coagulopathy in critical care unit
Status
Not Yet Recruiting
Last Updated
last year

Overview

Brief Summary

In intensive care units , sepsis remains one of the common causes of mortality and morbidity . The average hospital length of stay for sepsis is twice as long as any other fatal condition . Furthermore, sepsis survivors are at an increased risk of death or a reduced health related quality of life even after discharge from the hospital . Sepsis induces multiple and complex derangements in many systems including the coagulation cascade. The vast majority of septic patients present with hemostatic abnormalities ranging from subclinical coagulopathy to fulminant disseminated intravascular coagulation . During the initial stages of infection coagulation operates as a natural defense mechanism attempting to confine the responsible pathogen and prevent its spread into systematic circulation. However in advanced and severe infections as in sepsis, mass inflammatory cytokine production and release into the circulation lead to significantly deranged hemostatic balance . The coagulation process is activated while anticoagulant mechanisms including fibrinolysis and anticoagulant factors are suppressed. Consequently septic patients are prone to a prothrombotic state through four main mechanisms extrinsic pathway activation, cytokine induced coagulation amplification, anticoagulant pathways suppression, and fibrinolysis impairment .

Detailed Description

Sepsis is defined as a life-threatening syndrome associated with physiological, pathological and biological abnormalities caused by a dysregulated host response to infections . Globally, there are ∼48.9 million sepsis cases, leading to 11 million deaths annually . In intensive care units , sepsis remains one of the common causes of mortality and morbidity . The average hospital length of stay for sepsis is twice as long as any other fatal condition and the in-hospital mortality remains as high as 20% . Furthermore, sepsis survivors are at an increased risk of death or a reduced health-related quality of life even after discharge from the hospital . Sepsis induces multiple and complex derangements in many systems, including the coagulation cascade. The vast majority of septic patients present with hemostatic abnormalities, ranging from subclinical coagulopathy to fulminant disseminated intravascular coagulation (DIC) . During the initial stages of infection, coagulation operates as a natural defense mechanism, attempting to confine the responsible pathogen and prevent its spread into systematic circulation. However, in advanced and severe infections, as in sepsis, mass inflammatory cytokine production and release into the circulation lead to significantly deranged hemostatic balance . The coagulation process is activated, while anticoagulant mechanisms, including fibrinolysis and anticoagulant factors, are suppressed. Consequently, septic patients are prone to a prothrombotic state through 4 main mechanisms: extrinsic pathway activation, cytokine-induced coagulation amplification, anticoagulant pathways suppression, and fibrinolysis

Registry
clinicaltrials.gov
Start Date
September 10, 2024
End Date
August 2026
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Amira ahmed mohamed samony

Principal investigator

Assiut University

Eligibility Criteria

Inclusion Criteria

  • Patients with 18 years of ago or older who will be admitted to critical care unit with sepsis during period between october 2024 and october 2026.

Exclusion Criteria

  • patients under tge age of 18patients with end organ diseases
  • pregnant woman
  • patient with coagulation disorder
  • patient using anticoagulant drugs

Outcomes

Primary Outcomes

Assess frequency and severity of sepsis induced coagulopathy in critical care unit

Time Frame: 10/9/2024 - 1/10/2026

Assess frequency and severity of sepsis induced coagulopathy in critical care unit

Similar Trials